Capricor Therapeutics Stock Forecast
Volatile ride for Capricor Therapeutics stock price on Wednesday moving between $5.00 and $5.65
(Updated on Apr 24, 2024)
The Capricor Therapeutics stock price gained 4.56% on the last trading day (Wednesday, 24th Apr 2024), rising from $4.82 to $5.04. During the last trading day the stock fluctuated 12.93% from a day low at $5.00 to a day high of $5.65. The price has fallen in 7 of the last 10 days and is down by -20% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 435 thousand more shares were traded than the day before. In total, 913 thousand shares were bought and sold for approximately $4.60 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.87 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 58.61% during the next 3 months and, with a 90% probability hold a price between $7.72 and $12.52 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CAPR Signals & Forecast
Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Capricor Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.19 and $6.14. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -28.96%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Capricor Therapeutics stock
Capricor Therapeutics finds support from accumulated volume at $4.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.646 between high and low, or 12.93%. For the last week, the stock has had daily average volatility of 10.52%.
Capricor Therapeutics is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (CAPR) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Capricor Therapeutics to open at $5.23, and during the day (based on 14 day Average True Range), to move between $4.56 and $5.52, which gives a possible trading interval of +/-$0.475 (+/-9.43%) up or down from last closing price. If Capricor Therapeutics takes out the full calculated possible swing range there will be an estimated 18.85% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $5.05 (0.20%) than the support at $4.82 (4.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Capricor Therapeutics stock A Buy?
The Capricor Therapeutics stock holds several negative signals and despite the positive trend, we believe Capricor Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -2.261 Sell Candidate Downgraded
Predicted Opening Price for Capricor Therapeutics of Thursday, April 25, 2024
Fair opening price April 25, 2024 | Current price |
---|---|
$5.23 ( 3.75%) | $5.04 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CAPR
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 5.88 | 16.57 % | |
R2 | 5.63 | 11.67 % | ||
R1 | 5.48 | 8.64 % | ||
Current price: | 5.04 | |||
Support | S1 | 4.98 | -1.15 % | |
S2 | 4.83 | -4.18 % | ||
S3 | 4.58 | -9.08 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 5.89 | 16.87 % | |
R2 | 5.80 | 15.08 % | ||
R1 | 5.05 | 0.198 % | ||
Current price | 5.04 | |||
Support | S1 | 4.82 | -4.37% | |
S2 | 4.34 | -13.89% | ||
S3 | 3.91 | -22.42% |
FAQ
Click here for our free guide on how to buy Capricor Therapeutics Stock.